BNP Paribas Financial Markets’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-91,516
| Closed | -$169K | – | 3354 |
|
|
2023
Q1 | $169K | Buy |
91,516
+1,257
| +1% | +$2.33K | ﹤0.01% | 2580 |
|
|
2022
Q4 | $100K | Buy |
90,259
+70,383
| +354% | +$78.1K | ﹤0.01% | 2605 |
|
|
2022
Q3 | $46.5K | Buy |
19,876
+10,761
| +118% | +$25.2K | ﹤0.01% | 3284 |
|
|
2022
Q2 | $27.6K | Buy |
9,115
+4,623
| +103% | +$14K | ﹤0.01% | 3026 |
|
|
2022
Q1 | $30.5K | Sell |
4,492
-8,785
| -66% | -$59.7K | ﹤0.01% | 3091 |
|
|
2021
Q4 | $111K | Buy |
13,277
+3,871
| +41% | +$32.3K | ﹤0.01% | 2925 |
|
|
2021
Q3 | $69.9K | Buy |
9,406
+6,103
| +185% | +$45.3K | ﹤0.01% | 2822 |
|
|
2021
Q2 | $22.5K | Sell |
3,303
-4,524
| -58% | -$30.8K | ﹤0.01% | 2908 |
|
|
2021
Q1 | $80.4K | Buy |
7,827
+4,698
| +150% | +$48.2K | ﹤0.01% | 2885 |
|
|
2020
Q4 | $21.9K | Sell |
3,129
-608
| -16% | -$4.26K | ﹤0.01% | 3173 |
|
|
2020
Q3 | $30.5K | Buy |
3,737
+2,863
| +328% | +$23.4K | ﹤0.01% | 3053 |
|
|
2020
Q2 | $6.03K | Sell |
874
-4,187
| -83% | -$28.9K | ﹤0.01% | 3297 |
|
|
2020
Q1 | $24K | Buy |
5,061
+1,161
| +30% | +$5.52K | ﹤0.01% | 3243 |
|
|
2019
Q4 | $34K | Buy |
3,900
+1,311
| +51% | +$11.4K | ﹤0.01% | 3177 |
|
|
2019
Q3 | $8.62K | Sell |
2,589
-5
| -0.2% | -$17 | ﹤0.01% | 3537 |
|
|
2019
Q2 | $12.8K | Sell |
2,594
-744
| -22% | -$3.68K | ﹤0.01% | 3419 |
|
|
2019
Q1 | $20.7K | Buy |
3,338
+2,940
| +739% | +$18.2K | ﹤0.01% | 3307 |
|
|
2018
Q4 | $1.34K | Sell |
398
-237
| -37% | -$799 | ﹤0.01% | 3202 |
|
|
2018
Q3 | $4.13K | Sell |
635
-394
| -38% | -$2.56K | ﹤0.01% | 3460 |
|
|
2018
Q2 | $7.88K | Sell |
1,029
-2,108
| -67% | -$16.1K | ﹤0.01% | 3245 |
|
|
2018
Q1 | $70.1K | Buy |
3,137
+377
| +14% | +$8.43K | ﹤0.01% | 2799 |
|
|
2017
Q4 | $35.2K | Buy |
2,760
+2,131
| +339% | +$27.2K | ﹤0.01% | 3151 |
|
|
2017
Q3 | $9.8K | Sell |
629
-37
| -6% | -$576 | ﹤0.01% | 3322 |
|
|
2017
Q2 | $9.34K | Buy |
+666
| New | +$9.34K | ﹤0.01% | 3378 |
|